{"doi":"10.1016/j.jtct.2020.11.013","title":"Time to Complete Response after Defibrotide Initiation in Hepatic Veno-Occlusive Disease: Is Less Actually More?","abstract":null,"journal":"Transplantation and Cellular Therapy","year":2021,"id":626119,"datarank":0.16479184330021646,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"self_citation_contribution":0.16479184330021646,"citation_network_contribution":0.0,"self_endowment_contribution":0.16479184330021646,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":339785,"name":"Nasheed Hossain","orcid":"0000-0002-3278-655X","position":1,"is_corresponding":false},{"id":1142140,"name":"Patrick Hagen","orcid":"0000-0003-3428-1667","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Time to Complete Response after Defibrotide Initiation in Hepatic Veno-Occlusive Disease: Is Less Actually More?","abstract":null,"is_dataset_classified":null,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"33781546","pmcid":null,"openalex_id":"https://openalex.org/W3114689521","authors":[],"funders":[],"total_grants":0,"fwci":0.1138,"citation_percentile":0.4647985,"influential_citations":0,"citation_trend":[{"year":2023,"count":1},{"year":2025,"count":1}],"oa_status":"hybrid","license":"cc-by-nc-nd","oa_locations":[{"url":"https://www.sciencedirect.com/science/article/pii/S2666636720300397/pdf","host_type":"journal"},{"url":"https://www.sciencedirect.com/science/article/pii/S2666636720300397/pdf","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S2666636720300397?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S2666636720300397?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.jtct.2020.11.013","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/33781546","host_type":"repository"}],"fields_of_study":["Liver Disease and Transplantation","Liver Disease Diagnosis and Treatment","Hepatocellular Carcinoma Treatment and Prognosis","Hematopoietic Stem Cell Transplantation","Hepatic Veno-Occlusive Disease","Humans","Polydeoxyribonucleotides"],"mesh_terms":["Hepatic Veno-Occlusive Disease","Humans","Polydeoxyribonucleotides","Hematopoietic Stem Cell Transplantation"],"keywords":["Defibrotide","Hepatic veno-occlusive disease","Medicine","Internal medicine","Disease","Cardiology","Gastroenterology"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Zero hunger"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-04T12:30:12.277995Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}